Kiniksa Pharmaceuticals International, plc KNSA
CIK 0001730430
Form 4 transactions dated Sep 1, 2023 to Sep 27, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $0.00
- Sold
- $115.02M
Sep 1, 2023 – Sep 3, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2025-12-15 | Tessari Eben CHIEF OPERATING OFFICER | Sale10b5-1 footnote | $500.71K 12,048 shares sold | 41.96% sold Direct holding | ▾ |
| 2025-12-15 | Quart Barry D Director | Sale10b5-1 footnote | $835.55K 20,129 shares sold | 61.60% sold Direct holding | ▾ |
| 2025-12-08 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale10b5-1 footnote | $1.78M 42,841 shares sold | 57.95% sold Direct holding | ▾ |
| 2025-11-26 | Tessari Eben CHIEF OPERATING OFFICER | Sale10b5-1 footnote | $8.58K 200 shares sold | 0.87% sold Direct holding | ▾ |
| 2025-11-17 | Tessari Eben CHIEF OPERATING OFFICER | Sale10b5-1 footnote | $514.22K 12,470 shares sold | 35.44% sold Direct holding | ▾ |
| 2025-11-12 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale10b5-1 footnote | $814.71K 19,900 shares sold | 39.03% sold Direct holding | ▾ |
| 2025-10-31 | Paolini John F. CHIEF MEDICAL OFFICER | Sale10b5-1 footnote | $3.07M 82,542 shares sold | 57.37% sold Direct holding | ▾ |
| 2025-10-28 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale10b5-1 footnote | $4.10K 100 shares sold | 0.32% sold Direct holding | ▾ |
| 2025-10-22 | Patel Sanj K CHAIRMAN & CEO · Director | Sale10b5-1 footnote | $3.78M 97,390 shares sold | 46.56% sold Direct holding | ▾ |
| 2025-10-21 | Patel Sanj K CHAIRMAN & CEO · Director | Sale10b5-1 footnote | $1.52M 39,331 shares sold | 26.03% sold Direct holding | ▾ |
Showing 30 / 67 record groups in 2025. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 67 purchase / sale groups and 30 of 366 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"KNSA","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.